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Terpenoids are novel natural products isolated from mastic gum. Mastic 
gum was obtained from the Pistacia Lentiscus tree. Scientific investi-
gations have documented medical and pharmacological properties of 
mastic gum such as memory enhancement, antifungal, and antibacterial 
activities. It was astonishing to study the possible interaction of mastic 
gum extract with microtubule proteins which are involved in memory and 
consciousness since the administration of mastic gum is evidenced in the 
improvement of brain functions. Since a number of studies have demon-
strated the effect of microtubule dynamics on mammals' memory, in this 
study, we investigated the effect of Oxygenated Sesquiterpenes (OST) on 
microtubule polymerization in vitro. OST was purified from the ethanolic 
extract of mastic gum. The results revealed that OST induces microtubule 
polymerization; however, microtubule depolymerization was not affected 
and fluorometric assays showed conformational changes of tubulin in the 
presence of OST. We interestingly found that colchicine was unable to 
inhibit MT assembly in the presence of OST and OST was solely more 
efficient than the combination of OST with paclitaxel for elevating micro-
tubule polymerization rate. We hope that OST could be a promising agent 
for memory enhancement and the treatment of neurodegenerative diseas-
es as a novel tubulin-binding compound.
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1. Introduction
Pistacia lentiscus belongs to the Anacardiaceae fam-ily which is found in the Mediterranean regions [1]. Mastic gum is “well-known” for its terpenoid and 
essential oil compounds. The major components of mastic 
gum are consisted of flavonoids, triterpenoids, Oxygenat-
ed Sesquiterpenes (OST), phenolic compounds and some 
essential oils which show antifungal and antibacterial 
activities, and have been used for the treatment of hyper-
tension, dyspepsia, abdominal discomfort and patients 
suffering from peptic ulcers [2-6]. This study of mastic gum 
compounds originated from oriental traditional medicine 
papers which revealed wide usage of mastic gum for de-
creasing anxiety and stress [7], memory enhancement [7,8], 
antioxidant behavior [9] and anti-inflammatory activity 
[10]. At the other end of the spectrum, it has been shown 
that microtubule (MT) proteins, which particularly play 
essential structural and functional roles in brain cells, are 
involved in the memory system [11]. Therefore interaction 
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of OST with MT protein was the focus of this study.
MT proteins are dynamic polymers in all eukary-
otic cells which play key roles in a variety of cellular 
functions. They are composed of tubulin heterodimers 
including α-tubulin and β-tubulin which are able to be 
assembled from head to tail through binging to guanosine 
triphosphate (GTP) [12,13]. MTs are essential proteins per-
forming crucial roles in various cell functions such as mi-
tosis, cell motility and cellular transportation [14]. Axonal 
MTs are the major internal structures defining the external 
shape, polarity of the neuron and substance transportation 
including neurotransmitters [15]. MT stability is promoted 
by MT-associated proteins (MAPs) which bind to MT 
polymers and regulate the polymerization [13]. MT ends 
switch between growing and catastrophic state in vitro as 
well as in situ; this kind of behavior has been termed as 
dynamic instability [16]. Agents and drugs interfering with 
MT polymerization are able to have an impact on MT dy-
namics and functions [17]. 
Recent investigations indicated the crucial role of MT 
protein in the enhancement of memory. In 1993, Qian et 
al. have demonstrated abnormal MT polymerization of old 
rats' brains in comparison with the juvenile rats [18]. Other 
Researches in 2002 showed that the infusion of colchi-
cines into the rat bilateral rostrocaudal location has caused 
impaired memory function, which was due to the dysfunc-
tion of MTs [19]. Subsequent analyses have also confirmed 
the above-mentioned behavior of MT proteins [11,20]. Since 
MT dysfunction and instability are prominent in neuro-
degenerative diseases, e.g. Alzheimer’s, MT-stabilizing 
agents could compensate for the loss of MT organization 
and function [21]. The effect of crocin on MT polymeriza-
tion and structure in comparison with paclitaxel was pre-
viously reported in our lab indicating the ability of crocin 
for enhancing MT polymerization and nucleation rate as 
well as disruption of MT dynamics through acting as a 
stabilizing agent [22].
In this study, we have been searching for an effective 
molecular ligand interacting with MT proteins, which 
could stabilize MT polymers without any toxic effects. 
Hence, the impact of the ethanolic extract of mastic gum 
on MT dynamics was examined. At least four different 
compounds were accordingly isolated from ethanolic ex-
tract of mastic gum which revealed the adequate potency 
to induce MT polymerization in a concentration-depen-
dent manner. Optimization of a series of extracted com-
pounds resulted in obtaining OST, which was selected for 
further investigation because it displayed a high potential 
to stimulate MT polymerization. Moreover, we investi-
gated the effects of OST combination with colchicine and 
paclitaxel on MT dynamics. 
2. Materials and methods
2.1 Reagents
Paclitaxel and Colchicine (Aldrich Chemical Co.) were 
dissolved in DMSO before any usages. Phosphocellulose 
P11 was obtained from Whatman (Florham Park, USA). 
All other chemicals were purchased from Sigma Chemical 
Co. All solutions were prepared with double distilled wa-
ter and were kept at 4 ºC for further application.
2.2 Preparation and Identification of OST by 
HPLC and GC-Mass 
Pistacia lentiscus was granted by Professor. S. M. Ghaf-
fari, University of Tehran. Its fruits were collected and 
dried in darkness. The essential oils of mastic gum were 
obtained by the protocol described by Abidi et al. [23]. Four 
different compounds were isolated from the ethanolic 
extract of mastic gum by preparative HPLC. The most ef-
fective one was Oxygenated Sesquiterpene (OST) which 
has been mentioned in the following experiments. A C18 
reverse-phase column (150 × 3.9 mm inside diameter) was 
used with a 4 μm Nova-Pack C18 cartridge (Water, Mil-
ford, MA). The mobile phase consisted of HPLC was ace-
tonitrile and was run isocratically at a flow rate of 1 ml/
min. The elution was monitored at 308 nm. According to 
terpenoid elution time, the peaks were collected and OST 
was identified as C15H24O2 with a molecular weight of 236 
Dalton assessed by GC-mass spectrometry described by 
Ammari et al. [8]. The data was not displayed.
2.3 Tubulin Purification 
Tubulin was purified from the sheep's brain through two 
cycles of temperature-dependent polymerization-depo-
lymerization based on the Miller and Wilson method [24] 
with slight modifications. The fresh brain was homoge-
nized in PEM buffer (100 mM PIPES, 1 mM EGTA, 2 
mM MgSO4, and 1 mM ATP, pH 6.9) and the resulting 
homogenate was centrifuged for 30 min at 30000 g. The 
tubulin in the supernatant was polymerized for 45 min 
with the presence of Mg2+GTP and PMG buffer (100 mM 
PIPES, 2 mM MgSO4, 1 mM EGTA and 3.4 M glycerol, 
pH 6.9) was used as the polymerization buffer. MTs were 
pelleted by centrifugation (120,000g, 45 min), resuspend-
ed in PEM buffer 4°C for depolymerization process and 
then followed by one more cycle of polymerization-depo-
lymerization for further purification. In order to eliminate 
residual MAPs and other remained impurities, tubulin 
was subjected to the anion exchange chromatography in a 
phosphocellulose column P11 using the method revealed 
by Weingarten et al [25]. Purified tubulin was confirmed by 
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Coomassie Brilliant Blue staining of 10% SDS-PAGE and 
then stored at the liquid nitrogen. The protein concentra-
tion was measured using Bradford reagent (Bio-Rad, Her-
cules, USA) with bovine serum albumin as standard [26].
2.4 Microtubule Polymerization and Depolymer-
ization Assay 
The effect of OST on the MT polymerization-depo-
lymerization process was determined by turbidometric 
assays. Therefore, tubulin was incubated in PEM buffer 
with a final concentration of 2 mg/ml. Different con-
centrations of the substrates including OST, Paclitaxel, 
and Colchicine were consequently added to each sample 
cuvette. The tubulin assembly process was monitored by 
measuring the absorbance at 350 nm every 20 seconds 
at 37ºC after the addition of 1 mM GTP using a spectro-
photometer equipped with a temperature controller (Vari-
an, Melbourne, Australia). For disassembly assays, MTs 
incubated either with OST or alone were kept at 4°C and 
the absorbance changes were monitored at 350 nm. The 
depolymerized MT was re-polymerized at 37°C and the 
process was measured again as described above. 
2.5 Fluorescence Spectroscopy
8-anilino-1-naphthalenesulfonic acid (ANS) was used as a 
fluorophore to examine conformational changes of tubulin 
in the presence of OST. Tubulin (2 µM) was incubated in 
the presence of different concentrations of OST at 4 °C 
for 10 min. ANS (50 µM final concentration) was added 
to the tubulin-OST solution and incubated again for about 
7 min. The emissions were monitored between 450-550 
nm following excitation at 380 nm. All experiments were 
carried out at 4 ºC by Cary eclipse fluorescent spectropho-
tometer (Varian, Australia) and 2 µM tubulin was used in 
all measurements.
2.6 Transmission Electron Microscopy (TEM)
In-vitro polymerized MTs with and without OST (10 μM) 
were fixed on carbon-coated Farmavar-treated copper 
grids with 200 meshes. Each grid was then negatively 
stained with 10 μl uranyl acetate 1% solution. Excessive 
uranyl acetate was withdrawn with filter paper and sample 
grids were air-dried and observed using an HU-12A trans-
mission electron microscope (Hitachi, Japan).
2.7 Cell Culture
Two human neuroblastoma cell lines, SK-N-MC and SK-
N-BE (2), and fibroblast cell line, L929, were used as 
models for exploring the effects of OST on the brain cells. 
The SK-N-BE (2) cell line was cultured in Dulbecco’s 
modified Eagle’s medium (DMEM, Gibco BRL, Grand 
Island, NY) supplemented with 10% v/v fetal bovine se-
rum (FBS) (Gibco). SK-N-MC and fibroblast cell lines 
were grown in RPMI-1640 medium, supplemented with 
10% FBS. The cells were maintained in a humidified 
incubator supplied with 5% CO2 and 95% air at 37°C. 
For measuring the viability of the cells in the presence of 
various concentrations of OST, MTT (3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric 
assay was performed in a 96-well cell culture plate after 
incubation of the substrates for 24 hours.  Therefore, ab-
sorbance at 570 nm was determined for each well using 
Powerwave XS2 microplate spectrophotometer (BioTek, 
USA). The inhibition concentration (IC50) was calculated 
by linear regression, performed on the linear zone of the 
dose-response curve for absorbance readings [27]. Data 
were calibrated to the appropriate calibration curve. 
3. Results
3.1 Effect of OST on Tubulin Assembly and Disas-
sembly in Vitro
Turbidometric assays were done in order to investigate 
the effect of OST on MT polymerization-depolymeriza-
tion in vitro. Untreated MTs exhibited a temperature-de-
pendent polymerization-depolymerization cycle as long 
as Mg2+GTP was added. It is displayed that the addition 
of OST can promote MT polymerization in a concentra-
tion-dependent manner (2-10 µM) at 37 ºC (Figure 1). 
The re-polymerization assay demonstrated a similar result 
indicating the enhancement of the re-polymerization pro-
cess in the presence of increasing concentrations of OST 
(Figure 2). Therefore, it is can be conluded that OST has 
no effect on formation of tubulin aggregates and normal 
assembly-disassembly cycle of tubulin proteins in the 
presence of highet concentration of OST was observed 
(Figure 2). Moreover, TEM was applied to visualize the 
MTs structure treated with OST. Electron micrographs 
showed that MTs were formed and organized longer in 
the presence of OST with inflated intensity in comparison 
with control MT polymers (Figure 3).  
We additionally evaluated the combined effect of Pa-
clitaxel and OST on MT dynamics. MT was polymerized 
in the presence of 0.1 mM Paclitaxel and 10 µM OST to 
compare the OST effects with Paclitaxel on tubulin as-
sembly. Increased level of MT polymerization in the pres-
ence of OST was observed compared to Paclitaxel and a 
combination of OST and Paclitaxel (Figure 4). However, 
OST was not able to change the inhibitory effect of Pacli-
taxel on microtubule depolymerization.
To figure out the possible correlation between OST and 
DOI: https://doi.org/10.30564/jhp.v1i2.1589
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colchicine sites on MT proteins, polymerization was con-
ducted in the presence of 0.1 mM colchicine and 10 µM 
OST. The result has interestingly exceeded expectations. 
Turbidity  of tubulin-OST complex rocketed about three-
fold more than treatment with the combination of OST 
and colchicine (Figure 5). 
3.2 Effect of OST on MT Dynamics at Steady 
State
The results revealed that the addition of OST on assem-
bled microtubule solution at the equilibrium phase caused 
an increase in turbidity and the polymerization process 
initiated again to reach a new equilibrium state (Figure 6). 
It was comparable to the result obtained from the polym-
erization assay (Figure 1).
3.3 Effect of OST on the Tubulin Conformation 
To investigate the tubulin structural changes in the pres-
ence of OST, ANS fluorescence studies have been done. 
Tubulin-ANS complex manifests strong fluorescence abil-
ity that is extremely and environmentally sensitive. It is 
used to probe the conformational state of the tubulin and 
to determine the nature of the interactions [28]. The results 
revealed that the ANS fluorescence emission of tubulin 
was increased by an increment of OST concentrations due 
to the changes in the hydrophobic environment around the 
tubulin protein (Figure 7).
3.4 The Cell Culture Results
After 24 h incubation of OST with three cell lines in-
cluding SK-N-MC, SK-N-BE (2) and L929, the viability 
of them was determined above 80%. The morphological 
changes have not also occurred (the data was not shown) 
and the results have displayed no significant toxicity at the 
concentration ranged from 0.2 to 3.2 µM (Figure 8).
4. Discussion 
MT proteins are dynamic polymers encompassing tubulin 
subunits whose functions and stability are supposedly cor-
related to brain maintenance especially memory function [29]. 
The MT dynamicity is essential for neuronal proper activity 
and protection from neurodegeneration [30]. It is sensitive to 
various chemical agents targeting tubulin or MT polymers. 
The primary action of these agents is to bind to specific 
sites on the tubulin in order to alter the polymerization pro-
cess. Hence, finding a new stabilizing agent with low neu-
rotoxicity and harmful effects might open a new horizon 
for the treatment of neurodegenerative diseases [21]. Hence, 
the effects of ethanolic extract of mastic gum, which some 
evidence confirms its neuroprotective properties [31], on the 
tubulin structure and function were evaluated in vitro. 
The obtained outcomes indicated that OST could in-
crease the rate of MT polymerization in a dose-dependent 
manner and could change the MT steady-state equilibrium. 
The assembly-disassembly process in the presence of OST 
revealed that no aggregate formation was induced even 
at high concentrations. TEM images could confirm the 
results obtained from the turbidimetric assay, which illus-
trated the abundance of MT polymers with no aggregates 
formation in the presence of OST compared to the control. 
MT polymer is composed of an unstable tubulin-GDP core 
and a stable tubulin-GTP cap at its two distinct ends. The 
gain and loss of GTP cap originate a phenomenon called 
dynamic instability which is crucial in various brain cells 
functions particularly in cognition and memory [32,33]. OST 
may stabilize MTs by conformational changes inducing 
tubulin to cause more stable tubulin-GTP caps. However, 
the results suggested that OST has not negatively affected 
MT dynamic instability and the depolymerization process. 
It is also possible that OST might reduce the rate of GTP 
hydrolysis or Pi release, preventing the tubulin-GTP cap 
loss in order to stabilize MT polymers.
Since Paclitaxel is an effective antimitotic agent bind-
ing to tubulin to suppress the MT catastrophic phase and 
to enhance nucleation and elongation phases of MT po-
lymerization [34], the effect of Paclitaxel and OST along 
with their combinational effect on the tubulin assembly 
were compared. OST could enhance the MT polymeriza-
tion process similar to paclitaxel; however, the evidence 
showed that OST has not disrupted MT dynamic instabil-
ity and increased elongation rate significantly in contrast 
to Paclitaxel. It is indicated that the effect of paclitaxel 
on MT dynamic could not be inhibited in the presence 
of OST; however, the active sites for OST and paclitaxel 
might be the same or vicinal. Turbidimetry assay revealed 
that tubulin assembly increased in the presence of OST 
alone in comparison with the combination of paclitaxel 
and the same concentration of OST. Therefore, it seems 
that OST and paclitaxel may compete for binding to tubu-
lin. On a whole, it was shown that OST indicated more ef-
ficacy rather than the combination of OST with Paclitaxel 
for enhancement of MT polymerization rate.
Colchicine is a natural toxic product and an effective 
inhibitor of tubulin assembly in vitro. Colchicine binds to 
tubulin to form a tight complex and induces tubulin con-
formational change and the tubulin-colchicine complex 
inhibits MT growth [35]. Controversial to our expectation, 
we observed that colchicine, which usually has a devas-
tating impact on the MT polymer, could improve the sta-
bility of MTs when it was applied in the presence of OST. 
It seems that OST caused conformational changes in MT 
DOI: https://doi.org/10.30564/jhp.v1i2.1589
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structure that may interfere in the colchicine binding site 
and inhibit the action of colchicine; however, it is clear-
cut that colchicine has attenuated the stabilizing effect  of 
OST on tubulin assembly.
The fluorescence intensity emission of tubulin was 
identified in order to investigate tubulin conformational 
changes in the presence of increasing concentrations of 
OST. ANS is a fluorescence probe utilized to study the 
surface hydrophobicity of the protein after interacting with 
a ligand. Therefore, the protein-ANS complex provides 
beneficial data about the possible alterations of the protein 
conformation [36]. The obtained outcome demonstrated that 
the complex of OST-tubulin affected the tubulin confor-
mation due to the increment of ANS fluorescence emis-
sion of tubulin upon the addition of OST. In other words, 
OST could promote the exposure of tubulin hydrophobic 
regions, which have buried in the interior structure of the 
native tubulin, on the protein surface. The conformational 
changes of tubulin induced by OST binding could be an 
important factor for the enhancement of tubulin assembly. 
In conclusion, although OST could stabilize MT poly-
mers, it had no suppressive effects on their natural dynamic 
instability. We conclude that OST is a unique potent com-
pound that could interact with tubulin in order to induce MT 
polymerization. Further studies are required to define OST 
efficacy for the treatment of neurodegenerative diseases.
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Appendixes
Figure 1. Effect of OST on MT Polymerization in vitro
Note: Tubulin (2 mg/ml) was incubated at 37˚C in the presence of 1 mM 
GTP, different concentrations of OST, and the same volume of solvent 
as a control. MT polymerization was monitored by measuring turbidity 
every 20 seconds at 350 nm. 1) 0 µM OST (Control); 2) 2 µM OST; 3) 5 
µM OST; 4) 10 µM OST. The experiment was repeated four times.
Figure 2. MT Repolymerization Assay
Note: Polymerized MT polymer (2 mg/ml) was disassembled by cooling 
down to 4 °C and then re-warming 37 ºC  to induce reassembly without 
any further addition of GTP or OST. Repolymerization was monitored 
by measuring the absorbance value every 20 seconds at 350 nm.  a) 0 
µM OST (Control); b) 10 µM OST.
(a)
(b)
Figure 3. Electron Microscopy Micrographs of MT Pro-
teins
Note: MT proteins incubated with and without OST (10 µM) were neg-
atively stained with 1% uranil acetate. a) MT polymers without OST; 
b) OST-treated MT polymers after 25 min of polymerization initiation. 
(Scale bars = 0.5 micrometer).
DOI: https://doi.org/10.30564/jhp.v1i2.1589
23
Journal of Human Physiology | Volume 01 | Issue 02 | December 2019
Distributed under creative commons license 4.0
Figure 4.  Tubulin Assembly Induced by OST and Pacli-
taxel
Note: Tubilin proteins (2 mg/ml) were incubated with OST, mixture of 
OST and Paclitaxel and equal volume of solvent as a control. Turbidity 
changes were observed every 20 seconds at 350 nm. 1)  0 µM OST and 
Paclitaxel (Control); 2) 10 µM OST and 0.1 mM Paclitaxel; 3) 10 µM 
OST.
Figure 5. Tubulin Assembly Induced by OST and Colchi-
cines
Note: Tubulin proteins (2 mg/ml) were incubated with OST, mixture of 
OST and Colchicine, and equal volume of solvent as a control. Turbidity 
changes were monitored every 20 second at 350 nm. 1) 0 µM OST and 
Colchicine (Control); 2) 10 µM OST and 0.1 mM Colchicine; 3) 10 µM 
OST.
Figure 6. Effect of OST on MT Polymers at the Steady 
State Phase
Note: Tubulin proteins (2 mg/ml) were polymerized in the absence of 
OST. After 400 seconds from assembly initiation, various ranges of OST 
were added to the assembled tubulin in the steady state phase (displayed 
by the arrow). Polymerization process was recorded by turbidity changes 
at 350 nm. 1) 0 µM OST (Control); 2) 2 µM OST; 3) 5 µM OST; 4) 10 
µM OST.
Figure 7. ANS Fluorescence Emission of Tubulin 
Note: Tubulin proteins (2 µM) were incubated with various concentra-
tions of OST (0, 2, 5, 7, 10 µM) for 10 min at 4 ºC. ANS (50 μM final 
concentration) was added and after 10 min incubation, fluorescence 
emissions were recorded from 400 to 600 nm following excitation at 380 
nm. 1) 0 µM OST; 2) 2 µM OST; 3) 5 µM OST; 4) 7 µM OST; 5) 10 µM 
OST.
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Figure 8. Viability Results of the Cell Culture Assesments
Note: SK-N-MC, SK-N-BE (2) and L929 Cells were treated with dif-
ferent concentrations OST ranged from 0.2 to 3.2 μM for 24 h and their 
viability was evaluated using MTT colorimetric assay.
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